Stay updated on Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.

Latest updates to the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check39 days agoChange DetectedThe webpage has been updated to reflect a new version of the study, with the addition of the study's name 'Recurrent Plasma Cell Myeloma' and the principal investigator's name, Yvonne Efebera, MD. Additionally, the collaborators have been listed, and the registry identifier has been included.SummaryDifference42%
- Check46 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check89 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check104 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.